DICE Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
11.18 | 57.21 | -80.46% | -17.5 | -163.89% |
| P/S |
|
0 | 33.44 | -100% |
|
|
| P/BV |
|
2.17 | 4.65 | -53.23% |
|
|
| P/FCF |
|
-34.08 | 42.56 | -180.08% |
|
|
| Ev/Ebitda |
|
-9.45 | -17.68 | -46.54% |
|
|
| Ev/S |
|
0 | 22.52 | -100% |
|
|
| Ev/FCF |
|
-11.78 | 47.58 | -124.75% |
|
|
| E/P |
|
-0.036 | 0.0188 | -291.46% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -13.3 | -100% | -1770.61 | -100% |
| ROE |
|
56.07 | 9.69 | 478.6% |
|
|
| ROA |
|
-17.76 | 0.2896 | -6231.9% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.08 | -100% |
|
|
| ROCE |
|
-15.56 | 14.58 | -206.76% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1602 | -3.62 | -95.58% | -0.1382 | +15.95% |
| Nеt Debt/Ebitda |
|
5.4 | -4.05 | -233.26% |
|
|
| Debt/Ratio |
|
0.0224 | 0.1841 | -87.84% |
|
|
| Debt/Equity |
|
4.59 | 1.6 | 187.32% |
|
|
| Debt/Net Income |
|
-0.1628 | 0.9168 | -117.76% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5448 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4954 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5448 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-80.52 | 31.71 | -353.93% | ||
| Growth impulse Ebitda in 5 years |
|
676.31 | -23.28 | -3005.11% | ||
| Growth impulse Net Income in 5 years |
|
581.2 | -61.56 | -1044.12% | ||
| Growth impulse FCF in 5 years |
|
332.02 | -26 | -1377% | ||
| Growth impulse EPS in 5 years |
|
235.24 | -63.63 | -469.7% |
IP Score
4.1/10
